AstraZeneca

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AstraZeneca and other ETFs, options, and stocks.

About AZN

AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company’s history roots back to the year 1913 when Astra business was formed. 

CEO
Pascal Soriot
CEOPascal Soriot
Employees
94,300
Employees94,300
Headquarters
Cambridge, Cambridgeshire
HeadquartersCambridge, Cambridgeshire
Founded
1913
Founded1913
Employees
94,300
Employees94,300

AZN Key Statistics

Market cap
276.60B
Market cap276.60B
Price-Earnings ratio
29.20
Price-Earnings ratio29.20
Dividend yield
1.73%
Dividend yield1.73%
Average volume
4.80M
Average volume4.80M
High today
$89.18
High today$89.18
Low today
$88.21
Low today$88.21
Open price
$88.50
Open price$88.50
Volume
785.69K
Volume785.69K
52 Week high
$89.43
52 Week high$89.43
52 Week low
$61.24
52 Week low$61.24

Stock Snapshot

AstraZeneca(AZN) stock is priced at $88.75, giving the company a market capitalization of 276.6B. It carries a P/E multiple of 29.20 and pays a dividend yield of 1.7%.

On 2025-11-14, AstraZeneca(AZN) stock traded between a low of $88.21 and a high of $89.18. Shares are currently priced at $88.75, which is +0.6% above the low and -0.5% below the high.

AstraZeneca(AZN) shares are trading with a volume of 785.69K, against a daily average of 4.8M.

During the past year, AstraZeneca(AZN) stock moved between $61.24 at its lowest and $89.43 at its peak.

During the past year, AstraZeneca(AZN) stock moved between $61.24 at its lowest and $89.43 at its peak.

AZN News

TipRanks 3d
AstraZeneca Stock Hits 1-Year High — Here’s Why

Shares of British pharmaceutical giant AstraZeneca (AZN) jumped to their highest level in a year during early trading on Tuesday, surpassing the peak reached at...

The Motley Fool 4d
Why AstraZeneca Stock Was a Winner Today

The company inches closer to bringing a new drug to a very large addressable market. Good news from the laboratory put some zip into AstraZeneca (AZN +3.43%) s...

Why AstraZeneca Stock Was a Winner Today
Benzinga 4d
AstraZeneca's Investigational Hypertension Drug Shows Significant Blood Pressure Control In Pivotal Trial

AstraZeneca Plc (NASDAQ:AZN) shared on Monday full data from the Bax24 Phase 3 trial of once-daily 2mg baxdrostat versus placebo, on the reduction of ambulatory...

AstraZeneca's Investigational Hypertension Drug Shows Significant Blood Pressure Control In Pivotal Trial

Analyst ratings

81%

of 31 ratings
Buy
80.6%
Hold
16.1%
Sell
3.2%

More AZN News

TipRanks 4d
Compugen reports Q3 EPS (7c), consensus (9c)

Reports Q3 revenue $1.9M, consensus $1.47M. “I am thrilled to lead Compugen (CGEN) as our strong fundamentals and differentiated science gain clinical momentum,...

Nasdaq 5d
AstraZeneca's Baxdrostat Achieves Major Breakthrough In Hypertension Treatment In Phase III Trial

(RTTNews) - AstraZeneca PLC (AZN, AZN.L) announced results from its Bax24 Phase III trial, revealing that baxdrostat significantly reduced 24-hour systolic bloo...

AstraZeneca's Baxdrostat Achieves Major Breakthrough In Hypertension Treatment In Phase III Trial
Nasdaq 6d
Shore Capital Reiterates AstraZeneca Buy Recommendation

Fintel reports that on November 6, 2025, Shore Capital reiterated coverage of AstraZeneca (OTCPK:AZNCF) with a Buy recommendation. Analyst Price Forecast Sugge...

Shore Capital Reiterates AstraZeneca Buy Recommendation
TipRanks 7d
AstraZeneca’s Earnings Call Highlights Strong Growth and Future Ambitions

AstraZeneca ((AZN)) has held its Q3 earnings call. Read on for the main highlights of the call. Meet Your ETF AI Analyst Discover how TipRanks' ETF AI Analyst c...

TipRanks 7d
Midday Fly By: Musk pay plan approved, ‘GTA VI’ delayed

The major averages were broadly lower near noon, putting the biggest indices on track for a down week. Stocks tied to artificial intelligence and semiconductors...

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.